Vaginitis is the most common gynecologic diagnosis in the primary care setting. In approximately 90 percent of affected women, this condition occurs secondary to bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis or mixed infection. Neo-Penotran Forte is registered for treatment of these most common vaginal infections. Efficacy and safety of this product is already established, and this observational study was designed to learn more about practical use of Neo-Penotran® Forte in real life setting.
Study Type
OBSERVATIONAL
Enrollment
13,024
Patients older than 18 years with previously taken decision of their gynecologist to prescribe Neo-Penotran Forte according to registered indications, and microbiological tests were performed.
Unnamed facility
Many Locations, Kazakhstan
Percent rate of different vaginal infections
Time frame: Approximately within 6 months after the last patient last visit.
Clinical characteristics of vaginitis after treatment.
Time frame: Depending on treatment time chosen by the physician, after 7 or 14 days.
Change of microbiological characteristics after treatment
Time frame: Depending on treatment time chosen by the physician, after 7 or 14 days.
Patient rating of tolerability and treatment results
Time frame: Depending on treatment time chosen by the physician, after 7 or 14 days.
Physician's rating of tolerability and treatment results
Time frame: Depending on treatment time chosen by the physician, after 7 or 14 days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.